首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Bevacizumab/irinotecanVarious toxicities: 13 case reports
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2014年
/ 1498卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-014-0358-z
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:10 / 10
相关论文
共 50 条
[1]
Bevacizumab/irinotecanVarious toxicities: 4 case reports
Reactions Weekly,
2016,
1612
(1)
: 36
-
36
[2]
Bevacizumab/irinotecanVarious toxicities: 4 case reports
Reactions Weekly,
2014,
1532
(1)
: 54
-
54
[3]
IrinotecanVarious toxicities: 4 case reports
Reactions Weekly,
2021,
1853
(1)
: 260
-
260
[4]
IrinotecanVarious toxicities: 3 case reports
Reactions Weekly,
2023,
1962
(1)
: 227
-
227
[5]
IrinotecanVarious toxicities: 2 case reports
Reactions Weekly,
2022,
1909
(1)
: 307
-
307
[6]
Bevacizumab/cetuximab/irinotecanVarious toxicities: case report
Reactions Weekly,
2020,
1812
(1)
: 58
-
58
[7]
Cetuximab/irinotecanVarious toxicities: 6 case reports
Reactions Weekly,
2016,
1596
(1)
: 54
-
54
[8]
Cisplatin/irinotecanVarious toxicities: 9 case reports
Reactions Weekly,
2017,
1656
(1)
: 152
-
152
[9]
Bevacizumab/cisplatin/gemcitabineVarious toxicities: 13 case reports
Reactions Weekly,
2016,
1583
(1)
: 203
-
203
[10]
IrinotecanVarious toxicities: case report
Reactions Weekly,
2017,
1679
(1)
: 94
-
94
←
1
2
3
4
5
→